# FDA Inspection 1080821 - Embio Limited - January 31, 2019

Source: https://www.keypedia.com/records/fda_inspections/embio-limited/3c1f38e5-83c7-4dca-b99c-9234bb1c295d
Source feed: FDA_Inspections

> FDA Inspection 1080821 for Embio Limited on January 31, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1080821
- Company Name: Embio Limited
- Inspection Date: 2019-01-31
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1272275 - 2025-05-02](https://www.keypedia.com/records/fda_inspections/embio-limited/6fa93c55-4195-4e4c-bce6-4d23aaef0df9)
- [FDA Inspection 1272275 - 2025-05-02](https://www.keypedia.com/records/fda_inspections/embio-limited/cc9cdde1-049f-46b0-a5d5-0441fbb1aa24)
- [FDA Inspection 974222 - 2016-04-21](https://www.keypedia.com/records/fda_inspections/embio-limited/27892b32-bc3b-461b-8311-871fcec71a6d)
- [FDA Inspection 785569 - 2012-06-06](https://www.keypedia.com/records/fda_inspections/embio-limited/d0c74d37-5bce-474f-bb23-88cbcd096a4d)

Company: https://www.keypedia.com/companies/embio-limited/7dfd7e23-2130-4256-ac64-c3f2cb0e9d29

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c